AnalysisMode

SimCell: Transforming Bioprocessing Through Innovation As we look back at the impactful Testa Challenge 2023 by Testa Center in March, it's evident that SimCell has emerged as a pioneering solution in the realm of bioprocessing innovation. In this video, Tiago and Belma talk about AnalysisMode and SimCell, as well as the importance of innovation hubs such as Testa Center. SimCell, at its core, is a dynamic solution that seamlessly integrates data-driven modeling with advanced AI algorithms across key operational phases. From meticulous Pre-Simulation Preparation to the core Simulation and Analysis, and the crucial Validation and Implementation phase, SimCell is designed to revolutionize the bioprocessing landscape. The heart of SimCell's functionality lies in the Simulation and Analysis phase. By creating a virtual bioreactor and leveraging Scenario Testing, SimCell generates predictive models based on real-world data. This not only replicates the mAb production process but also provides invaluable insights into parameter impacts, paving the way for optimization. Testa Center serves as a dynamic innovation hub, propelling companies like AnalysisMode to new heights. The collaborative environment, coupled with hands-on interaction with challenge participants and industry partners, provides invaluable insights into the challenges small companies face. This collaborative spirit fosters a melting pot of ideas, pushing boundaries, and encouraging design thinking. As SimCell continues to shape the future of bioprocessing, we invite you to be part of this transformative journey. Stay tuned for more updates and innovations as we usher in a new era of efficiency, cost-effectiveness, and accessibility in cutting-edge therapy production. #SimCell #TestaChallenge2023 #BioprocessingRevolution #Innovation #AnalysisMode

[#BIOPC2024]- 📢 Belma Alispahic from AnalysisMode at the 9th edition of the #Bioproduction Congress (BIOPC) talked about Future-Proofing with AI-Powered Bioprocess Development @Mabdesign #BIOPC #BiologicsDevelopability #analyticalmethods #ProcessModeling #DigitalTwins #Quality #Regulatory #Bioproductioncongress #bioprocessing #innovation #BreakthroughInnovations #SustainableManufacturing

[#BIOPC2024] 📢 9th edition of the Bioproduction Congress (BIOPC) organized by MabDesign   🎙️ During the session “Process modeling & Digital twins”, you will hear about: -      Belma Alispahic from AnalysisMode -      Maxime Rantz from Genedata -      Eric Calvosa from Sanofi -      Mourad FERHAT, Ph.D from ACROBiosystems   📅 September 25-26, 2024 📍 Palais des congrès, Tours, France Agenda 👉 https://lnkd.in/gz2te9Ei Register 👉 https://lnkd.in/gz2fdUZU   MabDesign #BIOPC #Bioproductioncongress #bioproduction #bioprocessing #BiologicsDevelopability #AnalyticalMethods #ProcessModeling #DigitalTwins #SustainableManufacturing #Quality #Regulatory #BreakthroughInnovations

🚀 Excited to Present at the 9th Bioproduction Congress #BIOPC 2024! I'm thrilled to share that I’ll be presenting "Future-Proofing with AI-Powered Bioprocess Development" at BIOPC on September 25th. Why attend? 🔍 Top-notch insights: BIOPC is where industry leaders gather to explore the future of bioproduction. Expect cutting-edge topics like scaling production and innovative tech—must-know info for anyone in bioprocessing. What’s on the agenda? 💡 AI in Action: At AnalysisMode, we're pioneering AI-driven solutions to optimize efficiency, speed up time-to-market, and boost biopharmaceutical quality. I’ll share how AI can ‘future-proof’ bioprocesses, making them more resilient and adaptable. Why does this matter? 🧬 Complex Challenges: As biopharma grows more complex and personalized medicine rises, advanced, data-driven approaches are crucial. AI is set to revolutionize bioproduction, making processes more efficient and outcomes more predictable. Join the Conversation! 💬 What do you think? How will AI shape the future of bioproduction? What challenges or opportunities do you see ahead? Looking forward to connecting and discussing these exciting topics in Tours! 🇫🇷 #BIOPC #BioproductionCongress #Bioproduction #Bioprocessing #AI #AnalysisMode #FutureOfBiopharma MabDesign

Get ready for the 9th Bioproduction Congress #BIOPC on September 25-26, 2024, in Tours, France! Join Belma Alispahic, Chief Scientific Officer at AnalysisMode, as she presents in the Process Modeling & Digital Twins track. Belma will be sharing insights on "Future-Proofing with AI-Powered Bioprocess Development", showcasing how AI can transform bioprocessing efficiency and innovation. Don’t miss the chance to connect with Belma! Request a meeting through the online platform, and let's explore how AI can drive your bioproduction success. See you soon in Tours! 🇫🇷 #BIOPC #BioproductionCongress #Bioproduction #Bioprocessing MabDesign

Last week, we had a fantastic consortium meeting for the Horizon Europe LIBRA Project EU! 🌍 It was inspiring to see all the progress being made by our project partners in person and to reconnect with everyone. Learn more about the LIBRA project here: https://lnkd.in/dKyYz-i4 #HorizonEurope  #LIBRAProject #Biotechnology #Innovation #Bioprocessing  Belma Alispahic

AnalysisMode is proud to be a sponsor of the Festival of Biologics Basel 2024 on 15-17 October! This is Europe's largest biologics event - don't miss your chance to connect with industry leaders and experts. Register now to attend: https://lnkd.in/drwNsavH #festofbiologics #AI #AnalysisMode #bioprocessing

🚀 Reflections from the Bioprocessing Summit in Boston 🌐 We had the pleasure of attending the Bioprocessing Summit hosted by Cambridge Healthtech Institute in Boston, where we gained some powerful insights into the evolving role of AI in bioprocessing. Here are our top takeaways: 💡 Strategic AI Implementation: The importance of a well-planned, targeted AI strategy can’t be overstated. Success in bioprocessing requires aligning AI initiatives with specific goals and challenges. 📊 Measurable ROI: AI is more than a buzzword—it’s driving real efficiency, cost savings, and faster production. The key? Defining clear ROI metrics to track success. 📂 Real-World Case Studies: The event highlighted several impactful examples where AI optimized processes and improved product quality, underscoring its transformative potential. As AI continues to revolutionize bioprocessing, it’s crucial for companies to go beyond the hype and fully integrate AI into their workflows. At AnalysisMode, we’re committed to doing just that—delivering AI-powered insights and models that help bioprocessing labs optimize cell cultures through smarter data analysis and process modeling. 🔍 Strategic AI Implementation: We offer data-driven models tailored to your unique bioprocessing needs, boosting decision-making and efficiency. 💰 Measurable ROI: Our solutions deliver tangible improvements in efficiency, cost, and production speed. 🚀 Case Studies: See how AI has transformed process optimization and product quality in real-world scenarios. Ready to harness the full potential of your data? Let’s connect! #AIinBioprocessing #ProcessOptimization #DataDrivenDecisions #CHIBioprocessingSummit

🌟 AI in Bioprocess Development: Enhancing CRISPR Gene Editing 🌟 One of the most critical advancements in bioprocess development is the role of AI in enhancing the efficiency and precision of CRISPR gene editing. This breakthrough demonstrates how AI can dramatically improve the precision and efficiency of genetic modifications, paving the way for revolutionary applications in medicine and biotechnology. ❓ Why It Matters: AI-powered tools like DeepCRISPR and Elevation are transforming the CRISPR gene editing landscape. These tools use machine learning algorithms to predict both on-target and off-target effects of CRISPR edits. By accurately forecasting these outcomes, researchers can design more precise guide RNAs, significantly reducing the risk of unintended genetic alterations and improving the safety and effectiveness of gene editing processes 💪 Key Benefits: 1. Increased Accuracy: AI models analyze vast datasets to identify patterns that predict where CRISPR might cut unintended sites. This helps in designing guide RNAs that are more likely to hit the desired target without off-target effects. 2. Enhanced Efficiency: By predicting the most effective guide RNAs, AI reduces the trial-and-error aspect of gene editing, accelerating the development of gene therapies and other biotechnological applications. 3. Safety Improvements: Minimizing off-target effects is crucial for clinical applications of CRISPR. AI's ability to enhance precision ensures that gene editing is safer for use in humans, making it a more viable option for treating genetic disorders. 🌏 Real-World Impact: Recent studies have shown how these AI-driven advancements are already making a difference. For instance, the use of AI in CRISPR design has led to the development of more effective cancer treatments and improved agricultural crops. This not only speeds up research but also brings us closer to realizing the full potential of gene editing in addressing global challenges. AI is revolutionizing bioprocess development, and its integration with CRISPR technology exemplifies the power of combining computational intelligence with biological innovation. This synergy is set to drive significant advancements in medicine, agriculture, and beyond. #AI #CRISPR #Bioprocessing #Biotech #Innovation #PredictiveAnalytics --- Join #AnalysisMode in exploring the transformative impact of AI on bioprocess development. Share your insights and experiences! 🌟

The Impact of Bioprocessing Advancements on Drug Development Advancements in bioprocessing are revolutionizing drug development, driving efficiency, reducing costs, and accelerating time-to-market for new therapies. Here’s how: 💡 Increased efficiency and yield: Continuous processing and single-use systems streamline production, improve control, and lead to higher yields and better product quality. 💡 Improved quality and consistency: Real-time monitoring with Process Analytical Technology (PAT) and Quality by Design (QbD) frameworks ensure consistent quality and reduce batch failures. 💡 Faster development and scale-up: Predictive modeling and automation expedite process optimization, reducing the need for extensive trials. 💡 Cost reduction: Enhanced efficiency and predictive maintenance lower operational costs and prevent equipment failures. 💡 Enhanced collaboration: Digitalization fosters collaboration among manufacturers, suppliers, and regulators, driving innovation and ensuring regulatory compliance. At AnalysisMode, we leverage these advancements by providing cutting-edge data analytics and AI solutions that enhance bioprocessing efficiency and innovation. Our expertise helps clients optimize their processes, ensuring higher yields, better quality, and faster time-to-market for new therapies. Discover how AnalysisMode can transform your bioprocessing operations. Contact us today to learn more! https://lnkd.in/gRj4XgH4 #Bioprocessing #DrugDevelopment #AnalysisMode #QbD #Biotech